APO Research
Talk to an analyst

APO RESEARCH · REPORT

Luseogliflozin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Luseogliflozin Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchLuseogliflozin Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Luseogliflozin Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Luseogliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Luseogliflozin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Luseogliflozin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Luseogliflozin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Luseogliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Luseogliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Luseogliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Luseogliflozin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Luseogliflozin include Taisho Toyama, Novartis, Mitsubishi Tanabe Pharma and CR Double-Crane, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Luseogliflozin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Luseogliflozin, also provides the sales of main regions and countries. Of the upcoming market potential for Luseogliflozin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Luseogliflozin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Luseogliflozin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Luseogliflozin sales, projected growth trends, production technology, application and end-user industry.

Luseogliflozin Segment by Company

Taisho Toyama

Novartis

Mitsubishi Tanabe Pharma

CR Double-Crane

Luseogliflozin Segment by Type

2.5mg

5mg

Luseogliflozin Segment by Application

Periodontitis

Heart Disease

Diabetes

Luseogliflozin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Luseogliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Luseogliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Luseogliflozin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Luseogliflozin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Luseogliflozin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Luseogliflozin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Luseogliflozin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2.5mg Major Manufacturers Table 3. 5mg Major Manufacturers Table 4. Global Luseogliflozin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Periodontitis Major Manufacturers Table 6. Heart Disease Major Manufacturers Table 7. Diabetes Major Manufacturers Table 8. Luseogliflozin Industry Trends Table 9. Luseogliflozin Industry Drivers Table 10. Luseogliflozin Industry Opportunities and Challenges Table 11. Luseogliflozin Industry Restraints Table 12. Global Luseogliflozin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Luseogliflozin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Luseogliflozin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Luseogliflozin Revenue Market Share by Region (2021-2026) Table 16. Global Luseogliflozin Revenue Market Share by Region (2027-2032) Table 17. Global Luseogliflozin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Luseogliflozin Sales by Region (2021-2026) & (K Units) Table 19. Global Luseogliflozin Sales by Region (2027-2032) & (K Units) Table 20. Global Luseogliflozin Sales Market Share by Region (2021-2026) Table 21. Global Luseogliflozin Sales Market Share by Region (2027-2032) Table 22. Global Luseogliflozin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Luseogliflozin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Luseogliflozin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Luseogliflozin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Luseogliflozin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Luseogliflozin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Luseogliflozin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Luseogliflozin Manufacturers, Product Type & Application Table 30. Global Luseogliflozin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Luseogliflozin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Luseogliflozin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Luseogliflozin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Luseogliflozin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Luseogliflozin Revenue Market Share by Type (2021-2026) Table 37. Global Luseogliflozin Revenue Market Share by Type (2027-2032) Table 38. Global Luseogliflozin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 40. Global Luseogliflozin Sales by Type (2027-2032) & (K Units) Table 41. Global Luseogliflozin Sales Market Share by Type (2021-2026) Table 42. Global Luseogliflozin Sales Market Share by Type (2027-2032) Table 43. Global Luseogliflozin Price by Type (2021-2026) & (US$/Unit) Table 44. Global Luseogliflozin Price by Type (2027-2032) & (US$/Unit) Table 45. Global Luseogliflozin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Luseogliflozin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Luseogliflozin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Luseogliflozin Revenue Market Share by Application (2021-2026) Table 49. Global Luseogliflozin Revenue Market Share by Application (2027-2032) Table 50. Global Luseogliflozin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 52. Global Luseogliflozin Sales by Application (2027-2032) & (K Units) Table 53. Global Luseogliflozin Sales Market Share by Application (2021-2026) Table 54. Global Luseogliflozin Sales Market Share by Application (2027-2032) Table 55. Global Luseogliflozin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Luseogliflozin Price by Application (2027-2032) & (US$/Unit) Table 57. Taisho Toyama Company Information Table 58. Taisho Toyama Business Overview Table 59. Taisho Toyama Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Taisho Toyama Luseogliflozin Product Portfolio Table 61. Taisho Toyama Recent Development Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Novartis Luseogliflozin Product Portfolio Table 66. Novartis Recent Development Table 67. Mitsubishi Tanabe Pharma Company Information Table 68. Mitsubishi Tanabe Pharma Business Overview Table 69. Mitsubishi Tanabe Pharma Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Mitsubishi Tanabe Pharma Luseogliflozin Product Portfolio Table 71. Mitsubishi Tanabe Pharma Recent Development Table 72. CR Double-Crane Company Information Table 73. CR Double-Crane Business Overview Table 74. CR Double-Crane Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. CR Double-Crane Luseogliflozin Product Portfolio Table 76. CR Double-Crane Recent Development Table 77. North America Luseogliflozin Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Luseogliflozin Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 80. North America Luseogliflozin Sales by Type (2027-2032) & (K Units) Table 81. North America Luseogliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 82. North America Luseogliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 83. North America Luseogliflozin Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Luseogliflozin Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 86. North America Luseogliflozin Sales by Application (2027-2032) & (K Units) Table 87. North America Luseogliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 88. North America Luseogliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 89. North America Luseogliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Luseogliflozin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 91. North America Luseogliflozin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 92. North America Luseogliflozin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 93. North America Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 94. North America Luseogliflozin Sales by Country (2027-2032) & (K Units) Table 95. North America Luseogliflozin Sales Price by Country (2021-2026) & (US$/Unit) Table 96. North America Luseogliflozin Sales Price by Country (2027-2032) & (US$/Unit) Table 97. United States Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 98. Canada Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 99. Europe Luseogliflozin Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Luseogliflozin Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 102. Europe Luseogliflozin Sales by Type (2027-2032) & (K Units) Table 103. Europe Luseogliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 104. Europe Luseogliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 105. Europe Luseogliflozin Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Luseogliflozin Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 108. Europe Luseogliflozin Sales by Application (2027-2032) & (K Units) Table 109. Europe Luseogliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 110. Europe Luseogliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 111. Europe Luseogliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Luseogliflozin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. Europe Luseogliflozin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. Europe Luseogliflozin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 115. Europe Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 116. Europe Luseogliflozin Sales by Country (2027-2032) & (K Units) Table 117. Europe Luseogliflozin Sales Price by Country (2021-2026) & (US$/Unit) Table 118. Europe Luseogliflozin Sales Price by Country (2027-2032) & (US$/Unit) Table 119. Germany Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 120. France Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 121. U.K. Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 122. Italy Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 123. Netherlands Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 124. China Luseogliflozin Revenue by Type (2021-2026) & (US$ Million) Table 125. China Luseogliflozin Revenue by Type (2027-2032) & (US$ Million) Table 126. China Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 127. China Luseogliflozin Sales by Type (2027-2032) & (K Units) Table 128. China Luseogliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 129. China Luseogliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 130. China Luseogliflozin Revenue by Application (2021-2026) & (US$ Million) Table 131. China Luseogliflozin Revenue by Application (2027-2032) & (US$ Million) Table 132. China Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 133. China Luseogliflozin Sales by Application (2027-2032) & (K Units) Table 134. China Luseogliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 135. China Luseogliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Asia Luseogliflozin Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Luseogliflozin Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 139. Asia Luseogliflozin Sales by Type (2027-2032) & (K Units) Table 140. Asia Luseogliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 141. Asia Luseogliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 142. Asia Luseogliflozin Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Luseogliflozin Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 145. Asia Luseogliflozin Sales by Application (2027-2032) & (K Units) Table 146. Asia Luseogliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 147. Asia Luseogliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 148. Asia Luseogliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Luseogliflozin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Asia Luseogliflozin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Asia Luseogliflozin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 152. Asia Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 153. Asia Luseogliflozin Sales by Country (2027-2032) & (K Units) Table 154. Asia Luseogliflozin Sales Price by Country (2021-2026) & (US$/Unit) Table 155. Asia Luseogliflozin Sales Price by Country (2027-2032) & (US$/Unit) Table 156. Japan Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 157. South Korea Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 158. India Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 159. Australia Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 160. China Taiwan Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 161. Southeast Asia Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 162. SAMEA Luseogliflozin Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Luseogliflozin Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 165. SAMEA Luseogliflozin Sales by Type (2027-2032) & (K Units) Table 166. SAMEA Luseogliflozin Sales Price by Type (2021-2026) & (US$/Unit) Table 167. SAMEA Luseogliflozin Sales Price by Type (2027-2032) & (US$/Unit) Table 168. SAMEA Luseogliflozin Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA Luseogliflozin Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 171. SAMEA Luseogliflozin Sales by Application (2027-2032) & (K Units) Table 172. SAMEA Luseogliflozin Sales Price by Application (2021-2026) & (US$/Unit) Table 173. SAMEA Luseogliflozin Sales Price by Application (2027-2032) & (US$/Unit) Table 174. SAMEA Luseogliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. SAMEA Luseogliflozin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. SAMEA Luseogliflozin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. SAMEA Luseogliflozin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 178. SAMEA Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 179. SAMEA Luseogliflozin Sales by Country (2027-2032) & (K Units) Table 180. SAMEA Luseogliflozin Sales Price by Country (2021-2026) & (US$/Unit) Table 181. SAMEA Luseogliflozin Sales Price by Country (2027-2032) & (US$/Unit) Table 182. Brazil Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 183. Argentina Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 184. Chile Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 185. Colombia Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 186. Peru Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 187. Saudi Arabia Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 188. Israel Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 189. UAE Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 190. Turkey Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 191. Iran Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 192. Egypt Luseogliflozin Revenue (2021-2032) & (US$ Million) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Luseogliflozin Distributors List Table 196. Luseogliflozin Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Luseogliflozin Image Figure 2. Global Luseogliflozin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Luseogliflozin Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2.5mg Image Figure 5. 5mg Image Figure 6. Global Luseogliflozin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Luseogliflozin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Periodontitis Image Figure 9. Heart Disease Image Figure 10. Diabetes Image Figure 11. Global Luseogliflozin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Luseogliflozin Revenue (2021-2032) & (US$ Million) Figure 13. Global Luseogliflozin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Luseogliflozin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Luseogliflozin Revenue Market Share by Region (2021-2032) Figure 16. Global Luseogliflozin Sales (2021-2032) & (K Units) Figure 17. Global Luseogliflozin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Luseogliflozin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Luseogliflozin Sales YoY (2021-2032) & (K Units) Figure 20. Europe Luseogliflozin Sales YoY (2021-2032) & (K Units) Figure 21. China Luseogliflozin Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Luseogliflozin Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Luseogliflozin Sales YoY (2021-2032) & (K Units) Figure 24. Global Luseogliflozin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Luseogliflozin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Luseogliflozin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Luseogliflozin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Luseogliflozin Revenue Market Share by Type (2021-2032) Figure 30. Global Luseogliflozin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Luseogliflozin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Luseogliflozin Sales Market Share by Type (2021-2032) Figure 33. Global Luseogliflozin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Luseogliflozin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Luseogliflozin Revenue Market Share by Application (2021-2032) Figure 36. Global Luseogliflozin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Luseogliflozin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Luseogliflozin Sales Market Share by Application (2021-2032) Figure 39. North America Luseogliflozin Revenue Share by Type (2021-2032) Figure 40. North America Luseogliflozin Sales Share by Type (2021-2032) Figure 41. North America Luseogliflozin Revenue Share by Application (2021-2032) Figure 42. North America Luseogliflozin Sales Share by Application (2021-2032) Figure 43. North America Luseogliflozin Revenue Share by Country (2021-2032) Figure 44. North America Luseogliflozin Sales Share by Country (2021-2032) Figure 45. Europe Luseogliflozin Revenue Share by Type (2021-2032) Figure 46. Europe Luseogliflozin Sales Share by Type (2021-2032) Figure 47. Europe Luseogliflozin Revenue Share by Application (2021-2032) Figure 48. Europe Luseogliflozin Sales Share by Application (2021-2032) Figure 49. Europe Luseogliflozin Revenue Share by Country (2021-2032) Figure 50. Europe Luseogliflozin Sales Share by Country (2021-2032) Figure 51. China Luseogliflozin Revenue Share by Type (2021-2032) Figure 52. China Luseogliflozin Sales Share by Type (2021-2032) Figure 53. China Luseogliflozin Revenue Share by Application (2021-2032) Figure 54. China Luseogliflozin Sales Share by Application (2021-2032) Figure 55. Asia Luseogliflozin Revenue Share by Type (2021-2032) Figure 56. Asia Luseogliflozin Sales Share by Type (2021-2032) Figure 57. Asia Luseogliflozin Revenue Share by Application (2021-2032) Figure 58. Asia Luseogliflozin Sales Share by Application (2021-2032) Figure 59. Asia Luseogliflozin Revenue Share by Country (2021-2032) Figure 60. Asia Luseogliflozin Sales Share by Country (2021-2032) Figure 61. SAMEA Luseogliflozin Revenue Share by Type (2021-2032) Figure 62. SAMEA Luseogliflozin Sales Share by Type (2021-2032) Figure 63. SAMEA Luseogliflozin Revenue Share by Application (2021-2032) Figure 64. SAMEA Luseogliflozin Sales Share by Application (2021-2032) Figure 65. SAMEA Luseogliflozin Revenue Share by Country (2021-2032) Figure 66. SAMEA Luseogliflozin Sales Share by Country (2021-2032) Figure 67. Luseogliflozin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Luseogliflozin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg
  • 5mg
Applications
  • Periodontitis
  • Heart Disease
  • Diabetes
Companies covered
  • Taisho Toyama
  • Novartis
  • Mitsubishi Tanabe Pharma
  • CR Double-Crane

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Luseogliflozin Market by Type
  3. 1.2.1 Global Luseogliflozin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2.5mg
  5. 1.2.3 5mg
  6. 1.3 Luseogliflozin Market by Application
  7. 1.3.1 Global Luseogliflozin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Periodontitis
  9. 1.3.3 Heart Disease
  10. 1.3.4 Diabetes
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Luseogliflozin Market Dynamics
  1. 2.1 Luseogliflozin Industry Trends
  2. 2.2 Luseogliflozin Industry Drivers
  3. 2.3 Luseogliflozin Industry Opportunities and Challenges
  4. 2.4 Luseogliflozin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Luseogliflozin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Luseogliflozin Revenue by Region
  3. 3.2.1 Global Luseogliflozin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Luseogliflozin Revenue by Region (2021-2026)
  5. 3.2.3 Global Luseogliflozin Revenue by Region (2027-2032)
  6. 3.2.4 Global Luseogliflozin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Luseogliflozin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Luseogliflozin Sales by Region
  9. 3.4.1 Global Luseogliflozin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Luseogliflozin Sales by Region (2021-2026)
  11. 3.4.3 Global Luseogliflozin Sales by Region (2027-2032)
  12. 3.4.4 Global Luseogliflozin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Luseogliflozin Revenue by Manufacturers
  2. 4.1.1 Global Luseogliflozin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Luseogliflozin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Luseogliflozin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Luseogliflozin Sales by Manufacturers
  6. 4.2.1 Global Luseogliflozin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Luseogliflozin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Luseogliflozin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Luseogliflozin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Luseogliflozin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Luseogliflozin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Luseogliflozin Manufacturers, Product Type & Application
  13. 4.7 Global Luseogliflozin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Luseogliflozin Market CR5 and HHI
  16. 4.8.2 2025 Luseogliflozin Tier 1, Tier 2, and Tier 3
5 Luseogliflozin Market by Type
  1. 5.1 Global Luseogliflozin Revenue by Type
  2. 5.1.1 Global Luseogliflozin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Luseogliflozin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Luseogliflozin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Luseogliflozin Sales by Type
  6. 5.2.1 Global Luseogliflozin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Luseogliflozin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Luseogliflozin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Luseogliflozin Price by Type
6 Luseogliflozin Market by Application
  1. 6.1 Global Luseogliflozin Revenue by Application
  2. 6.1.1 Global Luseogliflozin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Luseogliflozin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Luseogliflozin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Luseogliflozin Sales by Application
  6. 6.2.1 Global Luseogliflozin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Luseogliflozin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Luseogliflozin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Luseogliflozin Price by Application
7 Company Profiles
  1. 7.1 Taisho Toyama
  2. 7.1.1 Taisho Toyama Company Information
  3. 7.1.2 Taisho Toyama Business Overview
  4. 7.1.3 Taisho Toyama Luseogliflozin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Taisho Toyama Luseogliflozin Product Portfolio
  6. 7.1.5 Taisho Toyama Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Luseogliflozin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Luseogliflozin Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Mitsubishi Tanabe Pharma
  14. 7.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 7.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 7.3.3 Mitsubishi Tanabe Pharma Luseogliflozin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mitsubishi Tanabe Pharma Luseogliflozin Product Portfolio
  18. 7.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 7.4 CR Double-Crane
  20. 7.4.1 CR Double-Crane Company Information
  21. 7.4.2 CR Double-Crane Business Overview
  22. 7.4.3 CR Double-Crane Luseogliflozin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CR Double-Crane Luseogliflozin Product Portfolio
  24. 7.4.5 CR Double-Crane Recent Developments
8 North America
  1. 8.1 North America Luseogliflozin Market Size by Type
  2. 8.1.1 North America Luseogliflozin Revenue by Type (2021-2032)
  3. 8.1.2 North America Luseogliflozin Sales by Type (2021-2032)
  4. 8.1.3 North America Luseogliflozin Price by Type (2021-2032)
  5. 8.2 North America Luseogliflozin Market Size by Application
  6. 8.2.1 North America Luseogliflozin Revenue by Application (2021-2032)
  7. 8.2.2 North America Luseogliflozin Sales by Application (2021-2032)
  8. 8.2.3 North America Luseogliflozin Price by Application (2021-2032)
  9. 8.3 North America Luseogliflozin Market Size by Country
  10. 8.3.1 North America Luseogliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Luseogliflozin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Luseogliflozin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Luseogliflozin Market Size by Type
  2. 9.1.1 Europe Luseogliflozin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Luseogliflozin Sales by Type (2021-2032)
  4. 9.1.3 Europe Luseogliflozin Price by Type (2021-2032)
  5. 9.2 Europe Luseogliflozin Market Size by Application
  6. 9.2.1 Europe Luseogliflozin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Luseogliflozin Sales by Application (2021-2032)
  8. 9.2.3 Europe Luseogliflozin Price by Application (2021-2032)
  9. 9.3 Europe Luseogliflozin Market Size by Country
  10. 9.3.1 Europe Luseogliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Luseogliflozin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Luseogliflozin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Luseogliflozin Market Size by Type
  2. 10.1.1 China Luseogliflozin Revenue by Type (2021-2032)
  3. 10.1.2 China Luseogliflozin Sales by Type (2021-2032)
  4. 10.1.3 China Luseogliflozin Price by Type (2021-2032)
  5. 10.2 China Luseogliflozin Market Size by Application
  6. 10.2.1 China Luseogliflozin Revenue by Application (2021-2032)
  7. 10.2.2 China Luseogliflozin Sales by Application (2021-2032)
  8. 10.2.3 China Luseogliflozin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Luseogliflozin Market Size by Type
  2. 11.1.1 Asia Luseogliflozin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Luseogliflozin Sales by Type (2021-2032)
  4. 11.1.3 Asia Luseogliflozin Price by Type (2021-2032)
  5. 11.2 Asia Luseogliflozin Market Size by Application
  6. 11.2.1 Asia Luseogliflozin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Luseogliflozin Sales by Application (2021-2032)
  8. 11.2.3 Asia Luseogliflozin Price by Application (2021-2032)
  9. 11.3 Asia Luseogliflozin Market Size by Country
  10. 11.3.1 Asia Luseogliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Luseogliflozin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Luseogliflozin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Luseogliflozin Market Size by Type
  2. 12.1.1 SAMEA Luseogliflozin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Luseogliflozin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Luseogliflozin Price by Type (2021-2032)
  5. 12.2 SAMEA Luseogliflozin Market Size by Application
  6. 12.2.1 SAMEA Luseogliflozin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Luseogliflozin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Luseogliflozin Price by Application (2021-2032)
  9. 12.3 SAMEA Luseogliflozin Market Size by Country
  10. 12.3.1 SAMEA Luseogliflozin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Luseogliflozin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Luseogliflozin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Luseogliflozin Value Chain Analysis
  2. 13.1.1 Luseogliflozin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Luseogliflozin Production Mode & Process
  6. 13.2 Luseogliflozin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Luseogliflozin Distributors
  9. 13.2.3 Luseogliflozin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst